LumiraDx

C-Reactive Protein Test
LumiraDx CRP Test

The LumiraDx CRP (C-Reactive Protein) test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the test delivers rapid, quantitative results in four minutes at the point of care.

Mas detalles

NT-proBNP Test
LumiraDx NT-proBNP Test

The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP levels in whole blood and plasma. It is the only quantitative direct fingerstick NT-proBNP test available today and delivers reliable, quantitative results in only 12 minutes at the point of need.

Mas detalles

PRUEBA DE HBA1C
LumiraDx HbA1c Test

La prueba de HbA1c de LumiraDx es una prueba IVD para la determinación cuantitativa de hemoglobina A1c (mmol/mol IFCC y % NGSP) en muestras de sangre venosa y capilar humana (EDTA), diseñada para usarse con el instrumento LumiraDx.

Mas detalles

Point Of Care Diagnostic System
LumiraDx

LumiraDx Platform is a high sensitivity point of care (POC) diagnostic system that combines a small, portable instrument, microfluidic test strip, simple, standardized workflow, and seamless, secure digital connectivity to the Cloud and hospital IT systems. It leverages testing methodologies used in lab analyzer systems, enabling healthcare providers to deliver lab-comparable performance and real-time results at the POC. The LumiraDx Platform integrates several technologies and sample types into a single instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings. The LumiraDx Platform currently offers COVID-19 antigen and antibody test capabilities, with a pipeline of over 30 tests across a range of assay technologies, including enzyme, immunoassay, molecular and electrolyte assays.

Mas detalles

SARS-CoV-2 Ag Test
LumiraDx SARS-CoV-2 Ag Test

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider within the first twelve days of symptom onset. Used with the LumiraDx Platform the test delivers rapid results at the point of care.

Mas detalles

SARS-CoV-2 Ag Pool Test
LumiraDx SARS-CoV-2 Ag Pool Test

The LumiraDx SARS-CoV-2 Ag Pool Test is a rapid microfluidic immunofluorescence assay for the qualitative detection of the nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens pooled from up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals. Used with the LumiraDx Platform the test offers a rapid, scalable and cost-effective screening solution for infectious individuals.

Mas detalles

SARS-CoV-2 Ab Test
LumiraDx SARS-CoV-2 Ab Test

The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.

Mas detalles

D-Dimer Test
LumiraDx D-Dimer Test

The LumiraDx D-Dimer Test is an easy to use fluorescence immunoassay designed to rapidly quantify D-Dimer levels in human whole blood and plasma at the point of care. It is the first quantitative micro-fluidic immunoassay of its kind, providing a precise and accurate D-Dimer result from a single direct fingerstick blood sample, in only six minutes.

Mas detalles

International Normalized Ratio (INR) Test
LumiraDx INR Test

The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the test delivers rapid results at the point of care.

Mas detalles

PRUEBA DE HBA1C
LumiraDx HbA1c Test

La prueba de HbA1c de LumiraDx es una prueba IVD para la determinación cuantitativa de hemoglobina A1c (mmol/mol IFCC y % NGSP) en muestras de sangre venosa y capilar humana (EDTA), diseñada para usarse con el instrumento LumiraDx.

Mas detalles

Point Of Care Diagnostic System
LumiraDx

LumiraDx Platform is a high sensitivity point of care (POC) diagnostic system that combines a small, portable instrument, microfluidic test strip, simple, standardized workflow, and seamless, secure digital connectivity to the Cloud and hospital IT systems. It leverages testing methodologies used in lab analyzer systems, enabling healthcare providers to deliver lab-comparable performance and real-time results at the POC. The LumiraDx Platform integrates several technologies and sample types into a single instrument, allowing for a continued development of a broad test menu across conditions diagnosed and managed in community-based healthcare settings. The LumiraDx Platform currently offers COVID-19 antigen and antibody test capabilities, with a pipeline of over 30 tests across a range of assay technologies, including enzyme, immunoassay, molecular and electrolyte assays.

Mas detalles

Ingresar.

Ver productos por categoría

Ver productos por categoría

LumiraDx

Covid-19 LumiraDx

Laboratorio clínico

Pruebas Punto de Atención

Sobre LumiraDx

Actualizado

Laboratorio clínico

Pruebas Punto de Atención